SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

REGOLI, Domenico
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.819
EU - Europa 1.923
AS - Asia 1.262
Continente sconosciuto - Info sul continente non disponibili 3
SA - Sud America 2
OC - Oceania 1
Totale 11.010
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.799
CN - Cina 749
UA - Ucraina 547
DE - Germania 437
TR - Turchia 337
IT - Italia 327
GB - Regno Unito 262
SG - Singapore 156
FI - Finlandia 126
SE - Svezia 114
FR - Francia 31
RU - Federazione Russa 30
BE - Belgio 26
CA - Canada 20
IN - India 7
CZ - Repubblica Ceca 6
IR - Iran 6
HR - Croazia 3
BG - Bulgaria 2
EU - Europa 2
GR - Grecia 2
JP - Giappone 2
NL - Olanda 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AL - Albania 1
AR - Argentina 1
AT - Austria 1
AU - Australia 1
CL - Cile 1
DK - Danimarca 1
EE - Estonia 1
IE - Irlanda 1
IQ - Iraq 1
KR - Corea 1
MM - Myanmar 1
NO - Norvegia 1
NP - Nepal 1
PL - Polonia 1
RO - Romania 1
Totale 11.010
Salva come PNG Salva come JPEG
Città #
Fairfield 1.109
Woodbridge 1.076
Houston 652
Jacksonville 612
Ann Arbor 559
Chandler 526
Ashburn 523
Seattle 401
Wilmington 392
Cambridge 352
Izmir 193
Nanjing 177
Beijing 169
Milan 123
Princeton 118
San Diego 109
Boardman 101
Singapore 94
New York 79
Shanghai 70
Dearborn 56
Nanchang 56
Shenyang 51
Falls Church 44
Bremen 34
Hebei 32
Auburn Hills 29
Jiaxing 29
Munich 29
Changsha 28
Ferrara 28
Mountain View 27
San Mateo 27
Jinan 26
Brussels 25
Tianjin 23
Mcallen 22
Norwalk 22
Philadelphia 20
Redwood City 20
Addison 19
Los Angeles 19
Kunming 17
Montréal 17
Zhengzhou 17
Helsinki 13
Indiana 12
Ningbo 12
Tappahannock 12
Des Moines 10
London 10
Augusta 7
Düsseldorf 7
Verona 7
Florence 6
Hounslow 6
Lanzhou 6
Leawood 6
Orange 6
Redmond 6
Washington 6
Bologna 5
Guangzhou 5
Ardabil 4
Brno 4
Changchun 4
Hangzhou 4
Monmouth Junction 4
Prescot 4
Taizhou 4
Chiswick 3
Edinburgh 3
Ferrara di Monte Baldo 3
Fuzhou 3
Hefei 3
Zagreb 3
Bolzano 2
Bondeno 2
Busto Arsizio 2
Chongqing 2
Montechiarugolo 2
New Bedfont 2
Olomouc 2
Portici 2
San Francisco 2
Seregno 2
Sofia 2
Southwark 2
Turin 2
Venice 2
Wandsworth 2
Acton 1
Asciano 1
Athens 1
Bari 1
Bordeaux 1
Boston 1
Caen 1
Carovigno 1
Cernobbio 1
Totale 8.379
Salva come PNG Salva come JPEG
Nome #
AGONISTI PIENI E PARZIALI ED ANTAGONISTI DEL RECETTORE PER NOCICETTINA/ORFANINA FQ AD ELEVATA POTENZA” 197
Characterization of FR 172357, a new non-peptide bradykinin B2 receptor antagonist, in human, pig and rabbit preparations 159
[(pF)Phe4,Arg14,Lys15]N/OFQ-NH2 (UFP-102), a highly potent and selective agonist of the nociceptin/orphanin FQ receptor 157
Structure-activity studies on the nociceptin/orphanin FQ receptor antagonist 1-benzyl-N-{3-[spiroisobenzofuran-1(3H),4'-piperidin-1-yl]propyl} pyrrolidine-2-carboxamide. 144
Human vascular kinin receptors of the B-2 type characterized by radioligand binding 141
N- and C-terminal modifications of nociceptin/orphanin FQ generate highly potent NOP receptor ligands 141
Kinin B-1 and B-2 receptors in pig vessels: characterization of two monoreceptor systems 140
[Nphe(1),Arg(14),Lys(15)]nociceptin-NH2, a novel potent and selective antagonist of the nociceptin/orphanin FQ receptor 134
Tryptophan replacement in the nociceptin/orphanin FQ receptor ligand Ac-RYYRWK-NH2 134
A new selective antagonist of the nociceptin receptor 133
Pharmacological characterization of nociceptin receptor: an in vitro study 131
Conformation-activity relationship of neuropeptide S and some structural mutants: Helicity affects their interaction with the receptor 129
A new ligand for the urotensin II receptor 126
UFP-112 a Potent and Long-Lasting Agonist Selective for the Nociceptin/Orphanin FQ Receptor 125
In vitro and in vivo studies on UFP-112, a novel potent and long lasting agonist selective for the nociceptin/orphanin FQ receptor 124
Identification of an achiral analogue of J-113397 as potent nociceptin/orphanin FQ receptor antagonist 123
Pharmacology of [Tyr(1)]nociceptin analogs: receptor binding and bioassay studies 123
Synthesis and biological activity of human neuropeptide S analogues modified in position 2 122
Effects of vasoactive agents in healthy and diseased human saphenous veins 120
Ala scan analogues of HOE 140. Synthesis and biological activities 117
Structure-activity study of the nociceptin(1-13)-NH2 N-terminal tetrapeptide and discovery of a nociceptin receptor antagonist 117
UFP-101 antagonizes the spinal antinociceptive effects of nociceptin/orphanin FQ; Behavioral and electrophysiological studies in mice 116
Structure-activity relationship study of position 4 in the urotensin-II receptor ligand U-II(4-11) 115
Endogenous nociceptin/orphanin FQ signalling produces opposite spinal antinociceptive and supraspinal pronociceptive effects in the mouse formalin test: Pharmacological and genetic evidences 113
Further studies on nociceptin-related peptides: Discovery of a new chemical template with antagonist activity on the nociceptin receptor 113
Pharmacological characterization of the nociceptin/orphanin FQ receptor non peptide antagonist Compound 24. 113
Synthesis and Biological Activity of Human Neuropeptide S Analogues Modified in Position 5: Identification of Potent and Pure Neuropeptide S Receptor Antagonists. 112
Address and message sequences for the nociceptin receptor: A structure-activity study of nociceptin-(1-13)-peptide amide 112
Dmt-Tic-NH-CH2-Bid (UFP-502), a potent DOP receptor agonist: In vitro and in vivo studies 111
null 111
[Nphe(1)]nociceptin-(1-13)NH2 selectively antagonizes nociceptin effects in the rabbit isolated ileum 108
Structure-activity relationship study on Tyr9 of urotensin-II(4-11): identification of a partial agonist of the UT receptor. 108
Characterization of nociceptin receptors in the periphery: in vitro and in vivo studies 108
Studies on the antinociceptive effect of [Nphe(1)]nociceptin(1-13)NH2 in mice 107
Pharmacological characterization of the nociceptin receptor mediating hyperalgesia in the mouse tail withdrawal assay 107
Pharmacological profile of hemokinin 1: a novel member of the tachykinin family 106
Structure-activity study at positions 3 and 4 of human neuropeptide S. 106
B1 and B2 kinin receptors in various species 105
Effects of human urotensin II in isolated vessels of various species; comparison with other vasoactive agents 104
Anxiolytic- and antidepressant-like activities of H-Dmt-Tic-NH-CH(CH2-COOH)-Bid (UFP-512), a novel selective delta opioid receptor agonist 104
[Arg(14), Lys(15)]nociceptin, a highly potent agonist of the nociceptin/orphanin FQ receptor: in vitro and in vivo studies 104
Pharmacological characterisation of novel kinin B2 receptor ligands 103
Effects of intrathecal nocistatin on the flexor reflex and its interaction with orphanin FQ nociceptin 103
Characterization of endothelin receptors in the human umbilical artery and vein 102
Pharmacology of the Kallikrein-Kinin system 102
Urotensin II stimulates plasma extravasation in mice via UT receptor activation 102
Nociceptin receptor activation inhibits tachykinergic non adrenergic non cholinergic contraction of guinea pig isolated bronchus 102
Bradykinin receptors and receptor ligands (with special emphasis on vascular receptors) 101
Urotensin II-induced hypotensive responses in Wistar-Kyoto (Wky) and spontaneously hypertensive (Shr) rats 101
UFP-101, a peptide antagonist selective for the nociceptin/orphanin FQ receptor 101
In vitro and in vivo pharmacological characterization of the novel NK(1) receptor selective antagonist Netupitant. 101
Urantide mimics urotensin-II induced calcium release in cells expressing recombinant UT receptors 101
The nociceptin/orphanin FQ receptor antagonist, [Nphe(1)]NC(1-13)NH2, potentiates morphine analgesia 100
null 99
Characterization of [Nphe(1)]nociceptin(1-13)NH2, a new selective nociceptin receptor antagonist 99
null 98
The mouse vas deferens: A pharmacological preparation sensitive to nociceptin 98
Receptors for kinins in the human isolated umbilical vein. 97
Changes in hippocampal and cortical B1 bradykinin receptor biological activity in two experimental models of epilepsy 97
Nociceptin receptor binding in mouse forebrain membranes: Thermodynamic characteristics and structure activity relationships 96
Altered anxiety-related behavior in nociceptin/orphanin FQ receptor gene knockout mice 96
Further studies at neuropeptide s position 5: discovery of novel neuropeptide S receptor antagonists. 96
Neurobiology, pharmacology, and medicinal chemistry of neuropeptide S and its receptor 95
Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl] methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol]: In vitro studies 95
Structure-activity relationship study on human urotensin II 95
Autoradiographic analysis of rat brain kinin B-1 and B-2 receptors: Normal distribution and alterations induced by epilepsy 94
Nociceptin/orphanin FQ inhibits electrically induced contractions of the human bronchus via NOP receptor activation 93
null 92
Synthesis and biological activity of nociceptin/orphanin FQ analogues substituted in position 7 or 11 with C alpha,alpha-dialkylated amino acids 92
Nociceptin/orphanin FQ receptor ligands, 91
Contractile activity of endothelins and their precursors in human umbilical artery and vein: identification of distinct endothelin-converting enzyme activities 90
Structure-activity studies of the Phe(4) residue of nociceptin(1-13)-NH2: Identification of highly potent agonists of the nociceptin/orphanin FQ receptor 90
Angiotensin II-induced increase of T-type Ca2+ current and decrease of L-type Ca2+ current in heart cells 90
Pharmacology of [tyr1]nociceptin analogs: receptor binding and bioassay studies 89
null 88
FR 173657: a new, potent, nonpeptide kinin B2 receptor antagonist. An in vitro study 88
Pharmacological profile of NOP receptors coupled with calcium signaling via the chimeric protein Galpha(qi5). 87
Pharmacology of nociceptin and its receptor: a novel therapeutic target 87
Nociceptin receptor antagonists display antidepressant-like properties in the mouse forced swimming test 86
Effects of naloxone benzoylhydrazone on native and recombinant nociceptin/orphanin FQ receptors 86
Further studies on nociceptin/orphanin FQ related peptides: discovery of a new chemical template with antagonist activity on the OP4 receptor. 85
null 84
Anxiolytic and antidepressant-like activities of UFP-512, a novel selective delta opiold receptor agonist 83
Characterization of the human vascular kinin B2 receptor by binding assays. 80
In vitro characterization of J-113397, a non-peptide nociceptin/orphanin FQ receptor antagonist 80
null 79
In vitro and in vivo pharmacological characterization of the novel UT receptor ligand [Pen(5), DTrp(7), Dab(8)] urotensin II(4-11) (UFP-803) 79
Highly potent full and partial agonists and anatagonists of the nociceptin/orphanin FQ receptor 78
Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8 ,9-tetrahydro-5H-benzocyclohepten-5-ol]: In vivo studies 75
Effects of Ro 64-6198 it nociceptin/orphanin FQ-sensitive isolated tissues 75
Structure-activity studies on neuropeptide S - Identification of the amino acid residues crucial for receptor activation 74
Neuropeptide S is a stimulatory anxiolytic agent: A behavioural study in mice 74
Expression and biological activity of B1 bradykinin receptors in two experimental models of epilepsy 73
Receptor binding profile of novel nociceptin/orphanin FQ receptor ligands in mouse brain membranes. 73
In vitro characterization of FR 190997, the first non peptide B2 receptor agonist receptor binding and bioassay in the human umbilical vein 73
ANALOGHI DERMASEPTINICI AD ATTIVITA’ ANTIMICROBICA 72
Pharmacological characterisation of [(pX)Phe(4)]nociceptin(1-13)amide analogues - 1. In vitro studies 70
Identificazione di un antagonista del recettore UT 67
MEN 11270, a novel selective constrained peptide antagonist with high affinity at the human B-2 kinin receptor 65
In vitro and in vivo pharmacological characterization of the neuropeptide S receptor antagonist [D-Cys(tBu)5]NPS. 64
Totale 10.246
Salva come PNG Salva come JPEG
Categoria #
all - tutte 43.480
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.480
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.644 384 91 86 374 182 312 224 287 219 262 145 78
2020/20211.495 142 158 60 214 68 159 53 177 30 166 204 64
2021/20221.308 44 137 96 98 87 56 73 72 57 94 123 371
2022/20231.347 126 52 62 173 225 177 113 100 199 7 68 45
2023/2024641 77 78 38 16 41 137 21 42 13 13 14 151
2024/202550 50 0 0 0 0 0 0 0 0 0 0 0
Totale 11.112